Showing results (131-140 of 662) with videos related to
Sort By:
Pageof 67
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1997
Radioassay of yttrium-90 radiation using the radionuclide dose calibratorQ A Salako, S J DeNardoThe Journal of Experimental Biology|April 14, 2017
When less means more: dehydration improves innate immunity in rattlesnakesGeorge A Brusch, Dale F DeNardoBreast Cancer Research : BCR|July 20, 2012
Battle over CCL2 for control of the metastatic niche: neutrophils versus monocytesJonathan B Mitchem, David G DeNardoComparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|December 3, 2005
Release of exendin-4 is controlled by mechanical action in Gila monsters, Heloderma suspectumCarolyn M Christel, Dale F DenardoJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1990
Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivoS V Deshpande, R Subramanian, M J McCall, et al.Nuclear Medicine and Biology|May 1, 1996
A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapyW D Erwin, M W Groch, D J Macey, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapyS Shen, G L DeNardo, T D Jones, et al.Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenograftsS J DeNardo, D L Kukis, L A Kroger, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodiesD A DeNardo, G L DeNardo, A Yuan, et al.European Journal of Nuclear Medicine|August 1, 1996
Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapyR B Wilder, G L DeNardo, S Sheri, et al.Pageof 67